Bisphosphonate remains highly localized after elution from porous implants.
BACKGROUND
Local elution of zoledronic acid from a porous implant reportedly enhances periimplant bone formation and implant fixation. However, there is no information in the literature on the extent to which eluted bisphosphonate remains localized around the implant or becomes systemically distributed.


OBJECTIVE
We ascertained to what extent eluted zoledronic acid remains local and whether there is systemic exposure after local elution from porous implants.


METHODS
A hydroxyapatite-coated porous tantalum implant dosed with 100 μg (14)C-labeled zoledronic acid was implanted into the left femoral intramedullary canal of six dogs. Bone samples near to and distant from the implant were harvested from three dogs at 6 weeks and three dogs at 52 weeks. The concentration of radiolabeled bisphosphonate in each sample was quantified using liquid scintillation spectrophotometry and its distribution in periimplant bone was revealed by exposing histologic sections to autoradiography film.


RESULTS
In all six dogs, the concentration of zoledronic acid in immediate periimplant bone was two orders of magnitude higher than in any other sampled tissue, averaging 732.6 ng/g at 6 weeks and 377.2 ng/g at 52 weeks. Minute amounts of zoledronic acid (≤ 7.2 ng/g) were detected throughout the skeleton, indicating some escape into the circulation after local elution. Autoradiographs revealed the greatest concentration of zoledronic acid on and within the implant, with rapid decrease short distances away and no uptake within the femoral cortex.


CONCLUSIONS
Zoledronic acid eluted from an implant remains mainly localized with minimal systemic distribution.


CONCLUSIONS
Local bisphosphonate elution reduces the risk of systemic side effects and skeletal bisphosphonate exposure.
McKenzie
Kimberly
K
Jo Miller Orthopaedic Research Laboratory, Montreal General Hospital, Montreal, Canada.
Dennis Bobyn
J
J
Roberts
Jacintha
J
Karabasz
Dorota
D
Tanzer
Michael
M
D000818:Animals; D001345:Autoradiography; D050071:Bone Density Conservation Agents / Q000737:chemistry / Q000493:pharmacokinetics*; D020099:Coated Materials, Biocompatible / Q000737:chemistry; D004164:Diphosphonates / Q000737:chemistry / Q000493:pharmacokinetics*; D004285:Dogs; D004337:Drug Carriers / Q000737:chemistry; D017886:Durapatite / Q000737:chemistry; D005269:Femur / Q000737:chemistry / Q000378:metabolism / Q000601:surgery; D007093:Imidazoles / Q000737:chemistry / Q000493:pharmacokinetics*; D010012:Osteogenesis; D019736:Prostheses and Implants; D019919:Prosthesis Implantation; D012588:Scintillation Counting; D012995:Solubility; D013635:Tantalum / Q000737:chemistry; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D020099:Coated Materials, Biocompatible; D004164:Diphosphonates; D004337:Drug Carriers; D007093:Imidazoles; D013635:Tantalum; D000077211:Zoledronic Acid; D017886:Durapatite
N Engl J Med. 2008 Mar 20;358(12):1304-6
18354114
J Bone Miner Res. 2007 Jun;22(6):867-76
17371160
N Engl J Med. 2007 May 3;356(18):1809-22
17476007
Bone. 2001 May;28(5):524-31
11344052
Bone. 2005 Jan;36(1):52-60
15664002
J Bone Miner Res. 2000 Apr;15(4):613-20
10780852
J Bone Joint Surg Am. 2008 Oct;90(10):2189-96
18829917
Ann N Y Acad Sci. 2007 Nov;1117:209-57
18056045
J Orthop Res. 2009 Feb;27(2):189-94
18752278
Acta Orthop Scand. 2000 Dec;71(6):553-7
11145380
J Bone Joint Surg Am. 2009 Nov;91 Suppl 6:23-31
19884409
Eur Cell Mater. 2008 Jul 31;16:10-6
18671203
N Engl J Med. 2007 Nov 1;357(18):1799-809
17878149
J Bone Joint Surg Am. 2008 May;90(5):1090-100
18451402
Bone. 2006 Oct;39(4):872-9
16765660
Hormones (Athens). 2009 Apr-Jun;8(2):96-110
19570737
Mayo Clin Proc. 2008 Sep;83(9):1032-45
18775204
Biomaterials. 2009 Mar;30(9):1790-6
19135249
J Bone Joint Surg Br. 2007 Mar;89(3):349-53
17356148
J Periodontol. 1999 Aug;70(8):893-5
10476897
Clin Orthop Relat Res. 2005 Dec;441:30-9
16330982
J Pharm Biomed Anal. 2002 Nov 7;30(4):897-911
12408879
Acta Orthop. 2007 Dec;78(6):795-9
18236186
J Biomed Mater Res A. 2006 Jan;76(1):133-43
16254957
J Orthop Res. 2004 Mar;22(2):244-9
15013081
N Engl J Med. 2008 Jul 17;359(3):316-7; author reply 317-8
18635442